NCM·Healthcare·$74M·#228 / 520 in Healthcare
CSBR Champions Oncology, Inc.
48SPECULATIVE
CATEGORY BREAKDOWN
GROWTH7
QUALITY50
STABILITY32
VALUATION99
GOVERNANCE97
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+4.4%
7
> 50% strong
Gross Margin
Revenue retained after direct costs
48.0%
67
> 50% strong
Cash Runway
Months of cash at current burn rate
13 months
44
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
114.5%
7
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.3x
99
< 3x strong
Rule of 40
Growth rate plus operating margin
3
24
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
26.7%
95
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-0.1%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CSBR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CSBR's score changes by 5+ points.
DATA INFO
Last updated: Aug 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.